About us

Our unique approach

KitoZyme at the heart of health

KitoZyme designs and manufactures innovative solutions to preserve and strengthen the health capital of people today and for generations to come.

With our commitment to combat major health problems, KitoZyme provides specialty ingredients and medical device products that are designed for several different market segments.

KitoZyme can be defined as a Life Sciences company that focuses on the following two main business lines:

  • Manufacturer of leading-edge functional biopolymers exclusively produced from renewable, non-GMO and vegetal sources. In this area, KitoZyme is the global pioneer in the production of biomass-derived biopolymers, non-animal chitosan and derivatives

  • Full-service provider of solutions in the Consumer Health Care market under regulations for medical devices.

We are at the meeting point of three industries, which used to be independent but are now increasingly interconnected: Food & Nutrition, Cosmetics and Medical Pharma.

KitoZyme is capable of providing our customers and partners with accurate core competencies in:

  • Science

    • Strong know-how in design, development, manufacturing and marketing of biopolymers based on renewable, non-animal and non-synthetic resources
    • Unique range of products
    • Unique set of approved or pending patents protecting products, processes, as well as use
    • Knowledge of structure-properties relationships and understanding mechanism of action on metabolism, cells etc.
    • Open innovation approach, close co-operation with major universities and state agencies
    • Agile development, creativity, solution-oriented innovation
  • Technology - A solid expertise in

    • Process and production of GMP or Food-Grade ingredients from biomass
    • Engineering of innovative manufacturing solutions for biopolymers that did not exist five years ago
    • Quality systems design and management
  • Market knowledge

    • Innovative, potent and well-documented ingredients
    • Having passed regulatory hurdles
    • World-class global distributors